Your browser doesn't support javascript.
loading
ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study.
Maris, Michael; Salles, Gilles; Kim, Won Seog; Kim, Tae Min; Lyons, Roger M; Arellano, Martha; Karmali, Reem; Schiller, Gary; Cull, Elizabeth; Abboud, Camille N; Batlevi, Connie; Kagiampakis, Ioannis; Rebelatto, Marlon C; Lee, Young; Kirby, Lyndon C; Wang, Fujun; Bothos, John; Townsley, Danielle M; Fathi, Amir T; Ribrag, Vincent.
Affiliation
  • Maris M; Colorado Blood Cancer Institute and Sarah Cannon Research Institute, Denver, CO, USA.
  • Salles G; Centre Hospitalier Lyon Sud, Pierre Benite, France.
  • Kim WS; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Kim TM; Seoul National University Hospital, Seoul, South Korea.
  • Lyons RM; Texas Oncology, US Oncology, San Antonio, TX, USA.
  • Arellano M; Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Karmali R; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Schiller G; David Geffen School of Medicine, UCLA Medical Center, Los Angeles, CA, USA.
  • Cull E; Prisma Health, Cancer Institute-Eastside, Greenville, SC, USA.
  • Abboud CN; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.
  • Batlevi C; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Kagiampakis I; Translational Medicine Bioinformatics, AstraZeneca, Gaithersburg, MD, USA.
  • Rebelatto MC; Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA.
  • Lee Y; Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA.
  • Kirby LC; Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA.
  • Wang F; Biostatistics, AstraZeneca, Gaithersburg, MD, USA.
  • Bothos J; Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA.
  • Townsley DM; Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA.
  • Fathi AT; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Ribrag V; Department of Hematology, Drug Development Department (DITEP), Institut Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif Cedex, France. vincent.ribrag@igr.fr.
Target Oncol ; 19(3): 321-332, 2024 May.
Article in En | MEDLINE | ID: mdl-38683495
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoconjugates / Hematologic Neoplasms Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Target Oncol Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Francia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoconjugates / Hematologic Neoplasms Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Target Oncol Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Francia